NMDA 受体在阿尔茨海默病中的作用的新进展。
New developments on the role of NMDA receptors in Alzheimer's disease.
机构信息
Center for Neural Circuits and Behavior, Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093, USA.
出版信息
Curr Opin Neurobiol. 2012 Jun;22(3):559-63. doi: 10.1016/j.conb.2011.09.001. Epub 2011 Sep 29.
Abstract
Since the initial findings that NMDA receptors play important roles in cellular models of learning as well as neurotoxicity, abnormal function of this receptor has been considered a potential mechanism in the pathophysiology underlying Alzheimer's disease. Treatment of Alzheimer's disease with an NMDA receptor antagonist began several years ago, with some limited success. More recent mechanistic studies have examined the role of NMDA receptors in the synaptic effects of beta amyloid (Aβ).
摘要
自最初发现 NMDA 受体在学习和神经毒性的细胞模型中发挥重要作用以来，该受体的异常功能已被认为是阿尔茨海默病病理生理学的潜在机制。几年前，开始使用 NMDA 受体拮抗剂治疗阿尔茨海默病，取得了一定的成效。最近的机制研究检查了 NMDA 受体在β淀粉样蛋白（Aβ）的突触效应中的作用。
相似文献
1
New developments on the role of NMDA receptors in Alzheimer's disease.
Curr Opin Neurobiol. 2012 Jun;22(3):559-63. doi: 10.1016/j.conb.2011.09.001. Epub 2011 Sep 29.
2
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.
Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.
3
Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
Rev Neurosci. 2011;22(3):285-94. doi: 10.1515/RNS.2011.029. Epub 2011 May 16.
4
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
CNS Neurosci Ther. 2013 Aug;19(8):549-55. doi: 10.1111/cns.12095. Epub 2013 Apr 18.
5
N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Alzheimers Dement. 2018 Oct;14(10):1302-1312. doi: 10.1016/j.jalz.2018.05.017. Epub 2018 Jul 4.
6
Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Neurol Res. 2019 Feb;41(2):139-150. doi: 10.1080/01616412.2018.1544745. Epub 2018 Nov 19.
7
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
Br J Pharmacol. 2012 Sep;167(2):324-52. doi: 10.1111/j.1476-5381.2012.02057.x.
8
An update on drug treatment options of Alzheimer's disease.
Front Biosci (Landmark Ed). 2014 Jun 1;19(8):1345-54. doi: 10.2741/4285.
9
Recent Progress in the Pharmacotherapy of Alzheimer's Disease.
Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.
10
Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Parkinsonism Relat Disord. 2007;13 Suppl 3:S329-31. doi: 10.1016/S1353-8020(08)70025-7.
引用本文的文献
1
Role of Ion Channels in Alzheimer's Disease Pathophysiology.
J Membr Biol. 2025 Jun;258(3):187-212. doi: 10.1007/s00232-025-00341-8. Epub 2025 May 1.
2
Early involvement of D-serine in β-amyloid-dependent pathophysiology.
Cell Mol Life Sci. 2025 Apr 28;82(1):179. doi: 10.1007/s00018-025-05691-z.
3
Investigating the Impact of NMDA Receptor Organization and Biological Sex in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
Int J Mol Sci. 2025 Feb 18;26(4):1737. doi: 10.3390/ijms26041737.
4
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
Transl Neurodegener. 2025 Feb 11;14(1):8. doi: 10.1186/s40035-025-00470-z.
5
Selective disruption of synaptic NMDA receptors of the hippocampal trisynaptic circuit in Aβ pathology.
Biol Res. 2024 Aug 22;57(1):56. doi: 10.1186/s40659-024-00537-7.
6
Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer's disease.
Neural Regen Res. 2025 Jul 1;20(7):1981-1988. doi: 10.4103/NRR.NRR-D-24-00398. Epub 2024 Jul 29.
7
APP fragment controls both ionotropic and non-ionotropic signaling of NMDA receptors.
Neuron. 2024 Aug 21;112(16):2708-2720.e9. doi: 10.1016/j.neuron.2024.05.027. Epub 2024 Jun 14.
8
Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease.
Int J Mol Sci. 2024 Apr 26;25(9):4757. doi: 10.3390/ijms25094757.
9
Limb-Clasping Response in NMDA Receptor Palmitoylation-Deficient Mice.
Mol Neurobiol. 2024 Nov;61(11):9125-9135. doi: 10.1007/s12035-024-04166-9. Epub 2024 Apr 9.
10
Mechanistic and structural studies reveal NRAP-1-dependent coincident activation of NMDARs.
Cell Rep. 2024 Feb 27;43(2):113694. doi: 10.1016/j.celrep.2024.113694. Epub 2024 Jan 23.
本文引用的文献
1
Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo.
J Neurosci. 2011 Aug 3;31(31):11328-37. doi: 10.1523/JNEUROSCI.0607-11.2011.
2
Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β.
Nat Neurosci. 2011 May;14(5):545-7. doi: 10.1038/nn.2785. Epub 2011 Mar 27.
3
Amyloid β peptide oligomers directly activate NMDA receptors.
Cell Calcium. 2011 Mar;49(3):184-90. doi: 10.1016/j.ceca.2011.02.001. Epub 2011 Feb 23.
4
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Neuropharmacology. 2011 May;60(6):982-90. doi: 10.1016/j.neuropharm.2011.01.051. Epub 2011 Feb 12.
5
Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.
Neuron. 2010 Dec 22;68(6):1067-81. doi: 10.1016/j.neuron.2010.11.030.
6
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.
Nat Neurosci. 2011 Jan;14(1):69-76. doi: 10.1038/nn.2709. Epub 2010 Dec 12.
7
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
Nature. 2011 Jan 6;469(7328):47-52. doi: 10.1038/nature09635. Epub 2010 Nov 28.
8
Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.
J Neurosci. 2010 Nov 24;30(47):15927-42. doi: 10.1523/JNEUROSCI.3021-10.2010.
9
Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors.
J Alzheimers Dis. 2010;22(2):541-56. doi: 10.3233/JAD-2010-100948.
10
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.
Cell. 2010 Aug 6;142(3):387-97. doi: 10.1016/j.cell.2010.06.036. Epub 2010 Jul 22.
Zotero 插件